These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3291561)

  • 21. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.
    Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM
    Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins.
    George E; Bedford C; Peacey SR; Hardisty CA; Heller SR
    Diabet Med; 1997 Jun; 14(6):442-8. PubMed ID: 9212308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
    Fanelli CG; Pampanelli S; Porcellati F; Rossetti P; Brunetti P; Bolli GB
    Ann Intern Med; 2002 Apr; 136(7):504-14. PubMed ID: 11926785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus.
    Porter PA; Byrne G; Stick S; Jones TW
    Arch Dis Child; 1996 Aug; 75(2):120-3. PubMed ID: 8869191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
    Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
    Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive function in type 1 (insulin-dependent) diabetic patients after nocturnal hypoglycaemia.
    Bendtson I; Gade J; Theilgaard A; Binder C
    Diabetologia; 1992 Sep; 35(9):898-903. PubMed ID: 1397787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unrecognised hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors.
    Wiltshire EJ; Newton K; McTavish L
    J Paediatr Child Health; 2006 Dec; 42(12):758-63. PubMed ID: 17096709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered recognition of hypoglycaemic symptoms in type I diabetes during intensified control with continuous subcutaneous insulin infusion.
    Lager I; Attvall S; Blohmé G; Smith U
    Diabet Med; 1986; 3(4):322-5. PubMed ID: 2949919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients: relation to daily median blood glucose concentrations.
    Thorsteinsson B; Pramming S; Lauritzen T; Binder C
    Diabet Med; 1986 Mar; 3(2):147-51. PubMed ID: 2951156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes.
    Matyka KA; Wigg L; Pramming S; Stores G; Dunger DB
    Arch Dis Child; 1999 Aug; 81(2):138-42. PubMed ID: 10490521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal hypoglycaemia in type 1 diabetes--consequences and assessment.
    DeVries JH; Wentholt IM; Masurel N; Mantel I; Poscia A; Maran A; Heine RJ
    Diabetes Metab Res Rev; 2004; 20 Suppl 2():S43-6. PubMed ID: 15551300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise-induced hypoglycaemia and subcutaneous insulin infusion.
    Edelmann E; Staudner V; Bachmann W; Walter H; Haas W; Mehnert H
    Diabet Med; 1986; 3(6):526-31. PubMed ID: 2951207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics.
    Gale EA; Tattersall RB
    Lancet; 1979 May; 1(8125):1049-52. PubMed ID: 86775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.
    Castillo MJ; Scheen AJ; Lefèbvre PJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1975-8. PubMed ID: 8626867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of insulin regimens in the therapy of type 1 diabetes.
    Pelkonen R; Koivisto V; Mustajoki P
    Acta Endocrinol Suppl (Copenh); 1985; 272():49-55. PubMed ID: 3914804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
    Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus.
    Schiel R; Burgard D; Perenthaler T; Stein G; Kramer G; Steveling A
    Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):99-104. PubMed ID: 26895277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial.
    Kalergis M; Schiffrin A; Gougeon R; Jones PJ; Yale JF
    Diabetes Care; 2003 Jan; 26(1):9-15. PubMed ID: 12502652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.